C4B and cyclic hematopoiesis: Subsequent work using techniques allowing for the detection of CH mutations with a VAF of ≥0.01% found the prevalence of CH to be nearly ubiquitous in persons older than 50 years of age, although the clinical significance of clones with such a low VAF is uncertain [18,19].